Nektar moving 30 research jobs to S.F.

Thirty research jobs will shift to San Francisco by July from a Nektar Therapeutics Inc. facility in Alabama, the company said Tuesday.
The move, the San Francisco-based drug developer (NASDAQ: NKTR) said, will consolidate all of its U.S. research and development work — biology, chemistry and clinical development — at its 102,283-square-foot Mission Bay location. After the move is complete, the San Francisco site will house about 230 employees.